Cupid
Cupid
Consumer GoodsKey Fundamentals
SmallcapPersonal CareConsumer GoodsTapetide Score
Data-driven rating, 0–100. How it works →
Key Insights
Strengths
3- Company is expected to give good quarter
- Company has delivered good profit growth of 31.3% CAGR over last 5 years
- Company's working capital requirements have reduced from 150 days to 119 days
Weaknesses
2- Stock is trading at 83.5 times its book value
- Though the company is reporting repeated profits, it is not paying out dividend
Growth Rate
AI Analysis — Bull vs Bear
Cupid Ltd, with a market cap of ₹37,751 Cr, has delivered explosive stock price appreciation of 589% over the past year alongside TTM sales growth of 116% and TTM profit growth of 188%. However, the stock trades at a PE of 272x and 82.7x book value, placing it in extremely elevated valuation territory relative to its fundamentals.
- TTM sales growth of 116% indicates a sharp acceleration in revenue, well above the 5-year compounded sales CAGR of 20%
- TTM profit growth of 188% significantly outpaces revenue growth, suggesting meaningful operating leverage and margin expansion
- 5-year compounded profit CAGR of 31% demonstrates consistent earnings growth over a longer horizon, not just a one-year spike
- Last year ROE of 28% is up from the 5-year average of 19%, indicating improving capital efficiency and higher returns for shareholders
- 10-year compounded sales CAGR of 19% and profit CAGR of 21% reflect a long track record of sustained double-digit growth
- Working capital days have reduced from 150 days to 119 days, freeing up cash and improving operational efficiency
- Dividend yield of 1.8% provides some income return, which is uncommon for high-growth small/mid-cap companies
- Stock price CAGR of 161% over 5 years and 61% over 10 years reflects prolonged wealth creation for long-term holders
- PE ratio of 272x is extraordinarily elevated, implying the stock prices in many years of flawless execution with no room for disappointment
- Price-to-book ratio of 82.7x is extreme by any benchmark and suggests the stock is trading far above its asset base
- 1-year stock price CAGR of 589% raises concerns about speculative momentum driving the price rather than fundamentals alone
- Despite reporting repeated profits, the company has not been consistently paying dividends, raising questions about capital allocation priorities
- Key financial metrics such as EPS, debt-to-equity, and ROCE are unavailable or null, limiting the ability to fully assess financial health
- 52-week high and low data are reported as 0, indicating potential data gaps that make technical and volatility assessment difficult
- The gap between 3-year stock CAGR of 314% and 3-year profit CAGR of 52% suggests valuation multiples have expanded aggressively beyond earnings growth
- At a market cap of ₹37,751 Cr with such elevated multiples, even a modest earnings miss could trigger sharp price corrections
This is AI-generated analysis, not financial advice. Do your own due diligence.
AI News Digest
- Aggressive promoter share accumulation Sep 9
Promoter Aditya Halwasiya bought over 78 lakh shares across seven open market transactions from Aug 17 to Sep 12, raising his stake from ~33.39% to 33.88% and promoter group holding to 46.83%.
- South Africa manufacturing JV Aug 28
Board gave in-principle approval for a South African JV to manufacture male condoms, with the local partner funding capex and Cupid holding up to 49% equity.
- Strong FY27-FY29 revenue guidance Aug 26
Cupid guided for FY27 revenue of ₹725-750 crore with net profit of ₹210-225 crore, and targets ₹1,500 crore revenue by FY29, implying ~2x growth in two years.
- Zero Scope 2 GHG emissions Aug 25
FY26 BRSR filing shows zero Scope 2 emissions, 12% capex allocated to environmental tech, and 100% MSME procurement, strengthening ESG credentials.
- 33rd AGM set for Sep 22 Aug 26
Cupid scheduled its 33rd AGM for September 22, 2026, to be conducted via video conferencing.
- New independent director appointed Aug 17
Keral Prasad Yadav appointed as Additional Non-Executive Independent Director for a five-year term effective August 17, 2026, subject to shareholder approval at the AGM.
TL;DR: Cupid Ltd presents a strongly bullish picture with its promoter aggressively accumulating shares over multiple weeks, signaling high insider confidence. The company's FY27 guidance of ₹725-750 crore revenue and ₹1,500 crore FY29 target point to ambitious growth, supported by international expansion via the South Africa JV. No material headwinds are visible in recent news, though execution risk on the doubling-revenue target and JV delivery remain factors to watch going forward.
Quarterly Results
| Particulars | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 35 | 36 | 40 | 66 | 44 | 47 | 51 | 61 | 65 | 90 | 104 | 132 | 157 |
| Expenses | 32 | 29 | 28 | 32 | 32 | 31 | 35 | 43 | 43 | 56 | 59 | 82 | 95 |
| Operating Profit | 3 | 7 | 12 | 34 | 12 | 16 | 16 | 18 | 21 | 34 | 45 | 50 | 62 |
| OPM % | 9% | 20% | 30% | 51% | 26% | 34% | 31% | 30% | 33% | 38% | 43% | 38% | 40% |
| Other Income | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Interest | 0 | 0 | 0 | 1 | 0 | 1 | 0 | 1 | 1 | 1 | 1 | 1 | 1 |
| Depreciation | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
| PBT | 2 | 6 | 12 | 32 | 11 | 14 | 14 | 16 | 20 | 32 | 43 | 47 | 60 |
| Tax % | 3% | 20% | 24% | 26% | 22% | 29% | 21% | 28% | 23% | 25% | 24% | 24% | 26% |
| Net Profit | 2 | 5 | 9 | 24 | 8 | 10 | 11 | 12 | 15 | 24 | 33 | 36 | 44 |
| EPS in Rs | 0.02 | 0.04 | 0.07 | 0.18 | 0.06 | 0.07 | 0.08 | 0.09 | 0.11 | 0.18 | 0.24 | 0.27 | 0.33 |
Profit & Loss
| Particulars | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 44 | 61 | 84 | 81 | 85 | 160 | 143 | 133 | 159 | 172 | 183 | 358 | 484 |
| Expenses | 32 | 36 | 50 | 53 | 65 | 108 | 107 | 109 | 118 | 121 | 141 | 239 | 292 |
| Operating Profit | 13 | 25 | 34 | 27 | 21 | 52 | 36 | 23 | 41 | 51 | 42 | 119 | 191 |
| OPM % | 29% | 41% | 41% | 34% | 24% | 33% | 25% | 17% | 26% | 30% | 23% | 33% | 40% |
| Other Income | 1 | 2 | 1 | 1 | 2 | 3 | 5 | 4 | 5 | 7 | 19 | 32 | 0 |
| Interest | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 0 | 1 | 2 | 2 | 3 | 3 |
| Depreciation | 2 | 2 | 2 | 2 | 2 | 2 | 3 | 3 | 3 | 3 | 4 | 5 | 5 |
| PBT | 11 | 25 | 32 | 26 | 21 | 53 | 38 | 25 | 42 | 53 | 55 | 142 | 183 |
| Tax % | 33% | 36% | 37% | 34% | 27% | 24% | 24% | 30% | 25% | 24% | 25% | 24% | — |
| Net Profit | 8 | 16 | 21 | 17 | 15 | 40 | 29 | 17 | 32 | 40 | 41 | 108 | 137 |
| EPS in Rs | 0.06 | 0.12 | 0.15 | 0.13 | 0.11 | 0.3 | 0.22 | 0.13 | 0.24 | 0.3 | 0.3 | 0.81 | 1.02 |
| Div. Payout % | 22% | 21% | 22% | 29% | 35% | 15% | 21% | 35% | 21% | 0% | 0% | 0% | — |
Balance Sheet
| Particulars | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 11 | 11 | 11 | 11 | 13 | 13 | 13 | 13 | 13 | 13 | 27 | 134 |
| Reserves | 13 | 25 | 43 | 55 | 63 | 90 | 118 | 129 | 154 | 288 | 315 | 316 |
| Borrowings | 2 | 1 | 0 | 2 | 2 | 31 | 0 | 9 | 6 | 12 | 19 | 56 |
| Other Liabilities | 8 | 14 | 9 | 10 | 15 | 30 | 22 | 23 | 16 | 7 | 11 | 46 |
| Total Liabilities | 35 | 51 | 63 | 78 | 93 | 165 | 152 | 174 | 189 | 320 | 372 | 553 |
| Fixed Assets | 16 | 16 | 16 | 16 | 21 | 26 | 29 | 31 | 36 | 58 | 67 | 67 |
| CWIP | 0 | 0 | 0 | 0 | 0 | 3 | 1 | 6 | 0 | 0 | 6 | 25 |
| Investments | 0 | 0 | 5 | 18 | 22 | 21 | 48 | 54 | 69 | 147 | 103 | 75 |
| Other Assets | 19 | 35 | 42 | 44 | 50 | 114 | 74 | 84 | 83 | 114 | 196 | 386 |
| Total Assets | 35 | 51 | 63 | 78 | 93 | 165 | 152 | 174 | 189 | 320 | 372 | 553 |
Cash Flow
| Particulars | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating | 7 | 13 | 20 | 3 | 18 | 19 | 42 | 10 | 33 | 8 | -11 | 46 |
| Investing | -1 | -1 | -5 | -9 | -14 | -37 | -9 | -13 | -22 | -80 | 45 | 28 |
| Financing | -3 | -6 | -4 | -3 | -5 | 16 | -33 | 3 | -11 | 99 | -1 | 35 |
| Net Cash Flow | 3 | 6 | 11 | -9 | 0 | -2 | 0 | -1 | 0 | 27 | 32 | 110 |
| Free Cash Flow | 6 | 11 | 17 | 1 | 12 | 8 | 38 | 2 | 30 | -17 | -31 | 21 |
| CFO/OP | 69 | 76 | 94 | 50 | 119 | 60 | 142 | 83 | 106 | 41 | 5 | 66 |
Ratios
| Particulars | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 67 | 79 | 59 | 100 | 97 | 95 | 65 | 84 | 59 | 102 | 134 | 103 |
| Inventory Days | 155 | 60 | 133 | 259 | 168 | 437 | 230 | 197 | 229 | 184 | 450 | 350 |
| Days Payable | 84 | 27 | 80 | 162 | 135 | 579 | 168 | 134 | 105 | 1 | 13 | 153 |
| Cash Conversion Cycle | 139 | 112 | 112 | 198 | 130 | -46 | 127 | 147 | 183 | 285 | 570 | 301 |
| Working Capital Days | 58 | 77 | 67 | 130 | 108 | 40 | 87 | 87 | 77 | 123 | 210 | 119 |
| ROCE % | 48% | 79% | 72% | 43% | 29% | 50% | 28% | 17% | 26% | 22% | 17% | 34% |
Insights
BetaAI-extracted from concalls & annual reports · figures as reported, with sources
Log in to view Cupid insights
66 extracted metrics + investor summaries across FY11–FY26.
Documents
Frequently Asked Questions about Cupid
What does Cupid Ltd do?
Where is Cupid Ltd (CUPID) listed?
Which sector does Cupid Ltd belong to?
What is the market capitalisation of Cupid Ltd?
What is the PE ratio of Cupid Ltd?
What is the 52-week high and low of Cupid Ltd?
Does Cupid Ltd pay dividends?
What is the Return on Equity (ROE) of Cupid Ltd?
Company Information
Established in 1993, CUPID Limited is India's premier manufacturer of male and female condoms, personal lubricant, and IVD kits.[1]
For AI agents and developers
Reading this as an AI agent, LLM or automated pipeline? Every page on Tapetide is also published as clean Markdown — no navigation, no scripts, just the data. Fetch https://tapetide.com/stocks/CUPID.md for Cupid Ltd: company profile, latest price, key fundamentals, the Tapetide Score, growth rates, quarterly and annual financial statements, shareholding pattern, technical indicators, analyst ratings and exchange filings.
Append .md to any Tapetide URL for the
same treatment. A full index of what we publish is at /llms.txt and /llms-full.txt. For live,
structured queries instead of documents, use our MCP server.